<p>K.J. Harrison &amp; Partners Inc 在最近向美国证券交易委员会（SEC）提交的文件中表示，其在丹纳赫公司（NYSE:DHR - 免费报告）的持股在第二季度减少了 22.2%。该基金在此期间出售了 1,500 股后，持有该综合企业的 5,265 股股票。K.J. Harrison &amp; Partners Inc 在丹纳赫的持股在最近一个季度末价值为 1,040,000 美元。</p>
<ul>
<li>藏在明处的人工智能投资机会：约翰逊控制公司分析</li>
</ul>
<p>其他几家机构投资者也最近增持或减持了该股票的持股。太平洋资本合伙公司在第一季度新购入了价值 7,175,000 美元的丹纳赫股票。OneDigital 投资顾问公司在第一季度将其在丹纳赫的持股增加了 4.7%。OneDigital 投资顾问公司目前持有 17,535 股该综合企业的股票，价值为 3,595,000 美元，此前在上个季度又增购了 793 股。布鲁克斯通资本管理公司在第一季度将其在丹纳赫的持股增加了 7.0%。布鲁克斯通资本管理公司目前持有 11,080 股该综合企业的股票，价值为 2,271,000 美元，此前在上个季度又增购了 723 股。Wayfinding Financial LLC 在第一季度新购入了价值 104,000 美元的丹纳赫股票。最后，世界投资顾问公司在第一季度将其在丹纳赫的持股增加了 13.8%。世界投资顾问公司目前持有 15,879 股该综合企业的股票，价值为 3,255,000 美元，此前在上个季度又增购了 1,923 股。机构投资者和对冲基金持有该公司 79.05% 的股票。</p>
<h2>丹纳赫价格表现</h2>
<p>丹纳赫公司（DHR）的股票周一开盘价为 215.63 美元。丹纳赫公司的 1 年最低价为 171.00 美元，1 年最高价为 258.23 美元。该股票的市值为 1,523.1 亿美元，市盈率为 44.46，市盈增长比率为 3.28，贝塔值为 0.77。该公司的债务与股本比率为 0.33，流动比率为 1.52，速动比率为 1.10。该公司的 50 日移动平均价格为 203.41 美元，200 日移动平均价格为 199.60 美元。</p>
<ul>
<li>3 只提供强劲价值和稳定性的股票</li>
</ul>
<p>丹纳赫（NYSE:DHR - 获取免费报告）最近于 10 月 21 日（星期二）公布了其财报。该综合企业报告季度每股收益（EPS）为 1.89 美元，超出分析师一致预期的 1.72 美元，超出幅度为 0.17 美元。丹纳赫的净利润率为 14.44%，股本回报率为 10.92%。该企业在本季度的收入为 60.5 亿美元，而分析师预期为 60 亿美元。在去年同期，该公司每股收益为 1.71 美元。与去年同期相比，该企业的收入增长了 4.4%。丹纳赫已将其 2025 财年的指导目标设定为每股收益在 7.700-7.800 之间。整体来看，卖方分析师预计丹纳赫公司今年将发布每股收益为 7.63 美元。</p>
<h2>丹纳赫宣布分红</h2>
<p>该公司最近还宣布了一项季度分红，该分红于 10 月 31 日（星期五）支付。9 月 26 日（星期五）登记在册的股东获得每股 0.32 美元的分红。这相当于年化分红为 1.28 美元，分红收益率为 0.6%。除息日期为 9 月 26 日（星期五）。丹纳赫的派息比率为 26.39%。</p>
<h2>内部交易活动</h2>
<ul>
<li>安捷伦科技受益于对持久化学品的打击</li>
</ul>
<p>在其他消息中，董事 Teri List 于 8 月 22 日（星期五）出售了 2,778 股该公司的股票。股票以 211.06 美元的平均价格出售，总交易额为 586,324.68 美元。交易后，该董事直接持有公司 20,751 股，价值为 4,379,706.06 美元。此次交易使其持股减少了 11.81%。该交易已在向 SEC 的法律文件中披露，相关文件可通过此链接获取。公司内部人士目前持有 11.10% 的股票。</p>
<h2>分析师评级变动</h2>
<p>DHR 已成为多份分析师报告的主题。加拿大皇家银行在 9 月 2 日（星期二）的研究报告中将丹纳赫的目标股价设定为 241.00 美元。Redburn Partners 在 10 月 8 日（星期三）的研究报告中将丹纳赫的目标股价设定为 220.00 美元。Cowen 在 10 月 22 日（星期三）的研究报告中重申了对丹纳赫的 “买入” 评级。Guggenheim 在 7 月 23 日（星期三）的研究报告中重申了 “买入” 评级，并将丹纳赫的目标股价设定为 250.00 美元。最后，Weiss Ratings 在 10 月 8 日（星期三）的研究报告中重申了对丹纳赫的 “持有（c-）” 评级。共有 18 位股票研究分析师对该股票给予 “买入” 评级，5 位分析师对该公司的股票给予 “持有” 评级。根据 MarketBeat.com 的数据，该股票的共识评级为 “适度买入”，平均目标价格为 243.39 美元。</p>
<p><strong>查看我们关于丹纳赫的最新报告</strong></p>
<h2>丹纳赫公司简介</h2>
<p>（免费报告）</p>
<p>丹纳赫公司在全球范围内设计、制造和销售专业、医疗、工业和商业产品及服务。生物技术部门提供生物处理技术、耗材和服务，以推进、加速和整合治疗药物的开发和生产；细胞系和细胞培养基开发服务；用于制造的细胞培养基、工艺液体和缓冲液；色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，例如全制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票，胜过丹纳赫</li>
<li>宠物是大生意：4 只值得加入您投资组合的大型宠物股票</li>
<li>适合任何市场的 3 只安全稳健股票</li>
<li>深入分析买卖价差</li>
<li>柠檬水股票在财报后是否会迎来大反弹？</li>
<li>股票拆分，真的会影响投资者吗？</li>
<li>卡特彼勒股票到年底可能超过 650 美元</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>您现在应该投资 1,000 美元在丹纳赫吗？</h2>
<p>在您考虑丹纳赫之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而丹纳赫并不在名单上。</p>
<p>虽然丹纳赫目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

丹纳赫

<p>K.J. Harrison & Partners Inc 在第二季度减少了对丹纳赫公司（NYSE:DHR）22.2% 的持股，出售了 1,500 股，剩余 5,265 股，市值为 1,040,000 美元。其他机构投资者也调整了他们的持股。丹纳赫报告了第三季度每股收益为 1.89 美元，超出预期，收入为 60.5 亿美元。该公司宣布每股季度分红为 0.32 美元。分析师评级各异，目标价格范围在 220 美元到 250 美元之间。丹纳赫股票开盘价为 215.63 美元，市值为 1,523.1 亿美元</p>

<p>K.J. Harrison &amp; Partners Inc lessened its stake in Danaher Corporation (NYSE:DHR - Free Report) by 22.2% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 5,265 shares of the conglomerate's stock after selling 1,500 shares during the period. K.J. Harrison &amp; Partners Inc's holdings in Danaher were worth $1,040,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>K.J. Harrison &amp; Partners Inc 在最近向美国证券交易委员会（SEC）提交的文件中表示，其在丹纳赫公司（NYSE:DHR - 免费报告）的持股在第二季度减少了 22.2%。该基金在此期间出售了 1,500 股后，持有该综合企业的 5,265 股股票。K.J. Harrison &amp; Partners Inc 在丹纳赫的持股在最近一个季度末价值为 1,040,000 美元。</p>
</div><ul>
<li>An AI Play Hiding in Plain Sight: A Look at Johnson Controls</li>
</ul>
<div class="lb-trans"><ul>
<li>藏在明处的人工智能投资机会：约翰逊控制公司分析</li>
</ul>
</div><p>Several other institutional investors have also recently added to or reduced their stakes in the stock. Pacific Capital Partners Ltd acquired a new position in shares of Danaher in the first quarter worth $7,175,000. OneDigital Investment Advisors LLC grew its stake in shares of Danaher by 4.7% in the first quarter. OneDigital Investment Advisors LLC now owns 17,535 shares of the conglomerate's stock worth $3,595,000 after acquiring an additional 793 shares in the last quarter. Brookstone Capital Management grew its stake in shares of Danaher by 7.0% in the first quarter. Brookstone Capital Management now owns 11,080 shares of the conglomerate's stock worth $2,271,000 after acquiring an additional 723 shares in the last quarter. Wayfinding Financial LLC acquired a new position in shares of Danaher in the first quarter worth $104,000. Finally, World Investment Advisors grew its stake in shares of Danaher by 13.8% in the first quarter. World Investment Advisors now owns 15,879 shares of the conglomerate's stock worth $3,255,000 after acquiring an additional 1,923 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.</p>
<div class="lb-trans"><p>其他几家机构投资者也最近增持或减持了该股票的持股。太平洋资本合伙公司在第一季度新购入了价值 7,175,000 美元的丹纳赫股票。OneDigital 投资顾问公司在第一季度将其在丹纳赫的持股增加了 4.7%。OneDigital 投资顾问公司目前持有 17,535 股该综合企业的股票，价值为 3,595,000 美元，此前在上个季度又增购了 793 股。布鲁克斯通资本管理公司在第一季度将其在丹纳赫的持股增加了 7.0%。布鲁克斯通资本管理公司目前持有 11,080 股该综合企业的股票，价值为 2,271,000 美元，此前在上个季度又增购了 723 股。Wayfinding Financial LLC 在第一季度新购入了价值 104,000 美元的丹纳赫股票。最后，世界投资顾问公司在第一季度将其在丹纳赫的持股增加了 13.8%。世界投资顾问公司目前持有 15,879 股该综合企业的股票，价值为 3,255,000 美元，此前在上个季度又增购了 1,923 股。机构投资者和对冲基金持有该公司 79.05% 的股票。</p>
</div><h2>Danaher Price Performance</h2>
<div class="lb-trans"><h2>丹纳赫价格表现</h2>
</div><p>Shares of DHR opened at $215.63 on Monday. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23. The stock has a market cap of $152.31 billion, a PE ratio of 44.46, a price-to-earnings-growth ratio of 3.28 and a beta of 0.77. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The firm has a fifty day moving average price of $203.41 and a 200 day moving average price of $199.60.</p>
<div class="lb-trans"><p>丹纳赫公司（DHR）的股票周一开盘价为 215.63 美元。丹纳赫公司的 1 年最低价为 171.00 美元，1 年最高价为 258.23 美元。该股票的市值为 1,523.1 亿美元，市盈率为 44.46，市盈增长比率为 3.28，贝塔值为 0.77。该公司的债务与股本比率为 0.33，流动比率为 1.52，速动比率为 1.10。该公司的 50 日移动平均价格为 203.41 美元，200 日移动平均价格为 199.60 美元。</p>
</div><ul>
<li>3 Stocks Offering Strong Value and Stability</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只提供强劲价值和稳定性的股票</li>
</ul>
</div><p>Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating analysts' consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business had revenue of $6.05 billion during the quarter, compared to analysts' expectations of $6 billion. During the same period in the prior year, the company earned $1.71 earnings per share. The business's revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.</p>
<div class="lb-trans"><p>丹纳赫（NYSE:DHR - 获取免费报告）最近于 10 月 21 日（星期二）公布了其财报。该综合企业报告季度每股收益（EPS）为 1.89 美元，超出分析师一致预期的 1.72 美元，超出幅度为 0.17 美元。丹纳赫的净利润率为 14.44%，股本回报率为 10.92%。该企业在本季度的收入为 60.5 亿美元，而分析师预期为 60 亿美元。在去年同期，该公司每股收益为 1.71 美元。与去年同期相比，该企业的收入增长了 4.4%。丹纳赫已将其 2025 财年的指导目标设定为每股收益在 7.700-7.800 之间。整体来看，卖方分析师预计丹纳赫公司今年将发布每股收益为 7.63 美元。</p>
</div><h2>Danaher Announces Dividend</h2>
<div class="lb-trans"><h2>丹纳赫宣布分红</h2>
</div><p>The company also recently declared a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher's payout ratio is 26.39%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，该分红于 10 月 31 日（星期五）支付。9 月 26 日（星期五）登记在册的股东获得每股 0.32 美元的分红。这相当于年化分红为 1.28 美元，分红收益率为 0.6%。除息日期为 9 月 26 日（星期五）。丹纳赫的派息比率为 26.39%。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部交易活动</h2>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技受益于对持久化学品的打击</li>
</ul>
</div><p>In other news, Director Teri List sold 2,778 shares of the business's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 11.10% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他消息中，董事 Teri List 于 8 月 22 日（星期五）出售了 2,778 股该公司的股票。股票以 211.06 美元的平均价格出售，总交易额为 586,324.68 美元。交易后，该董事直接持有公司 20,751 股，价值为 4,379,706.06 美元。此次交易使其持股减少了 11.81%。该交易已在向 SEC 的法律文件中披露，相关文件可通过此链接获取。公司内部人士目前持有 11.10% 的股票。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>DHR has been the subject of a number of analyst reports. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a research note on Tuesday, September 2nd. Redburn Partners set a $220.00 target price on shares of Danaher in a research note on Wednesday, October 8th. Cowen reiterated a &#34;buy&#34; rating on shares of Danaher in a research note on Wednesday, October 22nd. Guggenheim reiterated a &#34;buy&#34; rating and set a $250.00 target price on shares of Danaher in a research note on Wednesday, July 23rd. Finally, Weiss Ratings reiterated a &#34;hold (c-)&#34; rating on shares of Danaher in a research note on Wednesday, October 8th. Eighteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $243.39.</p>
<div class="lb-trans"><p>DHR 已成为多份分析师报告的主题。加拿大皇家银行在 9 月 2 日（星期二）的研究报告中将丹纳赫的目标股价设定为 241.00 美元。Redburn Partners 在 10 月 8 日（星期三）的研究报告中将丹纳赫的目标股价设定为 220.00 美元。Cowen 在 10 月 22 日（星期三）的研究报告中重申了对丹纳赫的 “买入” 评级。Guggenheim 在 7 月 23 日（星期三）的研究报告中重申了 “买入” 评级，并将丹纳赫的目标股价设定为 250.00 美元。最后，Weiss Ratings 在 10 月 8 日（星期三）的研究报告中重申了对丹纳赫的 “持有（c-）” 评级。共有 18 位股票研究分析师对该股票给予 “买入” 评级，5 位分析师对该公司的股票给予 “持有” 评级。根据 MarketBeat.com 的数据，该股票的共识评级为 “适度买入”，平均目标价格为 243.39 美元。</p>
</div><p><strong>View Our Latest Report on Danaher</strong></p>
<div class="lb-trans"><p><strong>查看我们关于丹纳赫的最新报告</strong></p>
</div><h2>Danaher Company Profile</h2>
<div class="lb-trans"><h2>丹纳赫公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.</p>
<div class="lb-trans"><p>丹纳赫公司在全球范围内设计、制造和销售专业、医疗、工业和商业产品及服务。生物技术部门提供生物处理技术、耗材和服务，以推进、加速和整合治疗药物的开发和生产；细胞系和细胞培养基开发服务；用于制造的细胞培养基、工艺液体和缓冲液；色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，例如全制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Danaher</li>
<li>Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio</li>
<li>3 Safe and Steady Stocks for Any Market</li>
<li>A Deeper Look at Bid-Ask Spreads</li>
<li>Is Lemonade Stock Set for a Big Squeeze After Earnings?</li>
<li>Stock Splits, Do They Really Impact Investors?</li>
<li>Caterpillar Stock Could Top $650 by Year’s End</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过丹纳赫</li>
<li>宠物是大生意：4 只值得加入您投资组合的大型宠物股票</li>
<li>适合任何市场的 3 只安全稳健股票</li>
<li>深入分析买卖价差</li>
<li>柠檬水股票在财报后是否会迎来大反弹？</li>
<li>股票拆分，真的会影响投资者吗？</li>
<li>卡特彼勒股票到年底可能超过 650 美元</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=DHR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Danaher Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资 1,000 美元在丹纳赫吗？</h2>
</div><p>Before you consider Danaher, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑丹纳赫之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而丹纳赫并不在名单上。</p>
</div><p>While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然丹纳赫目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

K.J. Harrison & Partners Inc 出售了丹纳赫公司（Danaher Corporation）$DHR 的股票